Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10004610HBVENSG00000100652.5protein_codingSLC10A1NoNo6554Q14973
TVIS10018348HBVENSG00000100652.5protein_codingSLC10A1NoNo6554Q14973
TVIS10027278HBVENSG00000100652.5protein_codingSLC10A1NoNo6554Q14973
TVIS10019982HBVENSG00000100652.5protein_codingSLC10A1NoNo6554Q14973
TVIS10019983HBVENSG00000100652.5protein_codingSLC10A1NoNo6554Q14973
TVIS10020463HBVENSG00000100652.5protein_codingSLC10A1NoNo6554Q14973
TVIS10020464HBVENSG00000100652.5protein_codingSLC10A1NoNo6554Q14973
TVIS10040814HBVENSG00000100652.5protein_codingSLC10A1NoNo6554Q14973
TVIS10040815HBVENSG00000100652.5protein_codingSLC10A1NoNo6554Q14973
TVIS10051658HBVENSG00000100652.5protein_codingSLC10A1NoNo6554Q14973
TCGA Plot Options
Drug Information
GeneSLC10A1
DrugBank IDDB15248
Drug NameBulevirtide
Target IDBE0003644
UniProt IDQ14973
Regulation Typeinhibitor
PubMed IDs32926353
CitationsKang C, Syed YY: Bulevirtide: First Approval. Drugs. 2020 Oct;80(15):1601-1605. doi: 10.1007/s40265-020-01400-1.
GroupsApproved; Investigational
Direct ClassificationPeptides
SMILES
Pathways
PharmGKB
ChEMBL